Honasa cancels Fluence Pharma acquisition
Honasa cancels Fluence Pharma acquisition. The decision follows regulatory and due diligence challenges. This撤回 affects Honasa's expansion into the pharma segment. Financial terms of the proposed deal were未 disclosed.
📊 STOCKS: HONASA | 🏢 SECTOR: Corporate | #MEDIUMIMPACT #M&A
This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.